Showing 1 - 3 results of 3 for search 'Hannah Schenk', query time: 0.04s Refine Results
  1. 1
    Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study

    Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study by Hannah Schenk, Dagny Holle, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Armin Scheffler

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies

    Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies by Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, Hannah Schenk, Christoph Kleinschnitz, Martin Glas, Dagny Holle

    Published 2022-07-01
    Get full text
    Article
  3. 3
    CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience

    CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience by Armin Scheffler, Hannah Schenk, Sebastian Wurthmann, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Dagny Holle

    Published 2021-09-01
    Get full text
    Article

Search Tools: